200 related articles for article (PubMed ID: 10599071)
1. [Bone scintigraphy and rhenium radioisotope management in the course of metastatic prostatic cancer].
Ostwald E; Sabri O; Cremerius U; Jakse G; Büll U
Nuklearmedizin; 1999; 38(7):302-5. PubMed ID: 10599071
[TBL] [Abstract][Full Text] [Related]
2. Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy.
Liepe K; Kropp J; Hliscs R; Franke WG
Clin Nucl Med; 2000 Nov; 25(11):901-4. PubMed ID: 11079588
[TBL] [Abstract][Full Text] [Related]
3. [Pathogenetic differentiation of the bone superscan using bone marrow scintigraphy].
Weckesser M; Müller-Mattheis VG; Vosberg H; Müller-Gärtner HW
Nuklearmedizin; 1998 Jun; 37(4):156-8. PubMed ID: 9650218
[TBL] [Abstract][Full Text] [Related]
4. Rhenium-186-HEDP palliative treatment in disseminated bone metastases due to prostate cancer.
Limouris G; Shukla SK; Manetou A; Kouvaris I; Plataniotis G; Triantafyllou N; Rigas AV; Vlahos L
Anticancer Res; 1997; 17(3B):1699-704. PubMed ID: 9179222
[TBL] [Abstract][Full Text] [Related]
5. [Use of bone scintigraphy in the evaluation of bone involvement by prostatic cancer treated with a LHRH-antiandrogen combination].
Lacourcière Y; Dupont A; Giguère M; Labrie F
Union Med Can; 1986 Apr; 115(4):229-34. PubMed ID: 3521035
[No Abstract] [Full Text] [Related]
6. [Local bone pain and osseous scintigraphic findings in patients with metastatic bone tumor].
Imaeda T; Iinuma G; Hirota K; Inoue A; Sone Y; Seki M; Suzuki M; Doi H
Kaku Igaku; 1988 Dec; 25(12):1319-27. PubMed ID: 3249457
[No Abstract] [Full Text] [Related]
7. Sub-super bone scan caused by bone marrow involvement of prostate cancer.
Seo Y; Shuke N; Yamamoto W; Usui K; Aburano T
Ann Nucl Med; 1999 Oct; 13(5):351-4. PubMed ID: 10582806
[TBL] [Abstract][Full Text] [Related]
8. Bone tracer uptake in urinary bladder stones.
Onur Demirkol M; Seymen H; Ihsan Kölgesiz A; Kadioğlu A
Clin Nucl Med; 2003 Apr; 28(4):337-9. PubMed ID: 12642723
[No Abstract] [Full Text] [Related]
9. Cold metastases detected by bone scintigraphy in aggressive lung cancer.
Martínez Carsí C; Ruíz Hernández G; Sánchez Marchori C; Oro Camps J; Perales Vila A
Nuklearmedizin; 1998; 37(8):292-6. PubMed ID: 9868712
[TBL] [Abstract][Full Text] [Related]
10. Gastric uptake during Re-186 HEDP bone scintigraphy.
Limouris GS; Skukla SK
Anticancer Res; 1997; 17(3B):1779-81. PubMed ID: 9179234
[TBL] [Abstract][Full Text] [Related]
11. Preserved value of bone scintigraphy for the detection of skeletal metastases in prostate cancer patients with low prostate-specific antigen levels: effect of hormonal therapy and poor histologic differentiation.
Caglar M; Tuncel M
Clin Nucl Med; 2002 Jul; 27(7):532-3. PubMed ID: 12072787
[No Abstract] [Full Text] [Related]
12. Remission of bone metastases after combined chemotherapy and radionuclide therapy with Re-186 HEDP.
Palmedo H; Grünwald F; Wagner U; Köhler S; Krebs D; Biersack HJ
Clin Nucl Med; 1998 Aug; 23(8):501-4. PubMed ID: 9712380
[TBL] [Abstract][Full Text] [Related]
13. Detection of noncalcified splenic hemangioma by radionuclide bone scan.
Cooper SG; Strauss EB; Levine AH
J Nucl Med; 1989 Jun; 30(6):1111-2. PubMed ID: 2738692
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
[TBL] [Abstract][Full Text] [Related]
15. [Scintigraphic control of bone metastases of prostatic cancer treated with cytonal and cyclophosphamide].
Grossmann J; Weiss M; Deckart H; Raatzsch H
Radiobiol Radiother (Berl); 1988; 29(6):736-8. PubMed ID: 3253797
[No Abstract] [Full Text] [Related]
16. Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results.
Roudier MP; Vesselle H; True LD; Higano CS; Ott SM; King SH; Vessella RL
Clin Exp Metastasis; 2003; 20(2):171-80. PubMed ID: 12705638
[TBL] [Abstract][Full Text] [Related]
17. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.
Pollen JJ; Witztum KF; Ashburn WL
AJR Am J Roentgenol; 1984 Apr; 142(4):773-6. PubMed ID: 6230903
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of bone scan in patients with metastatic prostate cancer treated initially with androgen deprivation therapy.
Rigaud J; Tiguert R; Le Normand L; Karam G; Glemain P; Buzelin JM; Bouchot O
J Urol; 2002 Oct; 168(4 Pt 1):1423-6. PubMed ID: 12352409
[TBL] [Abstract][Full Text] [Related]
19. [Intraoperative localization of metastases with a hand-held gamma probe].
Adams S; Hovy L; Baum RP; Adams M; Maul FD; Kahla-Witzsch H; Zichner L; Jonas D; Hör G
Nuklearmedizin; 1995 Aug; 34(4):161-4. PubMed ID: 7675647
[TBL] [Abstract][Full Text] [Related]
20. Misleading renal stasis on bone scintigraphy in diffuse symmetrical skeletal metastases of prostatic carcinoma.
Kalin B; Jacobsson H
Rofo; 1987 Oct; 147(4):465-6. PubMed ID: 2825278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
